The  	The  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
immunoglobulin  	immunoglobulin  	 JJ	B-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	O
solid  	solid  	 JJ	O
organ  	organ  	 NN	B-NP
transplantation 	transplantation 	 NN	I-NP
:  	:  	 :	O
an  	an  	 DT	O
evidence-based  	evidence-based  	 JJ	O
practice  	practice  	 NN	B-NP
guideline  	guideline  	 VBD	I-NP
This  	This  	 DT	O
guideline  	guideline  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
immunoglobulin  	immunoglobulin  	 NNS	B-NP
( 	( 	 -LRB-	O
IG 	IG 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
sensitized  	sensitized  	 JJ	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	O
solid  	solid  	 JJ	B-NP
organ  	organ  	 NN	I-NP
transplantation  	transplantation  	 NN	I-NP
( 	( 	 -LRB-	O
SOT 	SOT 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
an  	an  	 DT	O
initiative  	initiative  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
Canadian  	Canadian  	 JJ	O
Blood  	Blood  	 NNP	O
Services  	Services  	 NNPS	O
and  	and  	 CC	O
the  	the  	 DT	O
National  	National  	 NNP	B-NP
Advisory  	Advisory  	 NNP	I-NP
Committee  	Committee  	 NNP	I-NP
on  	on  	 IN	O
Blood  	Blood  	 NNP	O
and  	and  	 CC	O
Blood  	Blood  	 NNP	O
Products  	Products  	 NNPS	O
of  	of  	 IN	O
Canada  	Canada  	 NNP	O
to  	to  	 TO	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
provide  	provide  	 VBP	O
guidance  	guidance  	 VBN	O
for  	for  	 IN	O
Canadian  	Canadian  	 JJ	O
practitioners  	practitioners  	 NNS	B-NP
involved  	involved  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
care  	care  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
SOT  	SOT  	 NNP	I-NP
and  	and  	 CC	O
transfusion  	transfusion  	 JJ	B-NP
medicine  	medicine  	 NN	I-NP
specialists  	specialists  	 NNS	I-NP
on  	on  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
IG  	IG  	 NNP	B-NP
and  	and  	 CC	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
standardize  	standardize  	 JJ	O
care 	care 	 NN	O
,  	,  	 ,	O
limit  	limit  	 VB	O
adverse  	adverse  	 JJ	O
events 	events 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
optimize  	optimize  	 JJ	B-NP
patient  	patient  	 NN	I-NP
care 	care 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
systematic  	systematic  	 JJ	B-NP
expert  	expert  	 NN	I-NP
and  	and  	 CC	O
bibliography  	bibliography  	 JJ	B-NP
literature  	literature  	 NN	I-NP
search  	search  	 NN	I-NP
up  	up  	 RP	O
to  	to  	 TO	O
July  	July  	 NNP	O
2008  	2008  	 CD	O
was  	was  	 VBD	O
conducted 	conducted 	 VBN	O
,  	,  	 ,	O
with  	with  	 IN	O
791  	791  	 CD	O
literature  	literature  	 NN	B-NP
citations  	citations  	 NNS	I-NP
and  	and  	 CC	O
45  	45  	 CD	O
reports  	reports  	 NNS	O
reviewed 	reviewed 	 VBN	O
.  	.  	 .	O
To  	To  	 TO	O
validate  	validate  	 VB	O
the  	the  	 DT	O
recommendations 	recommendations 	 NNS	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
guideline  	guideline  	 NN	O
was  	was  	 VBD	O
sent  	sent  	 VBN	O
to  	to  	 TO	O
physicians  	physicians  	 VB	O
involved  	involved  	 VBN	O
in  	in  	 IN	O
SOT  	SOT  	 NNP	O
in  	in  	 IN	O
Canada  	Canada  	 NNP	O
and  	and  	 CC	O
a  	a  	 DT	O
patient  	patient  	 JJ	O
representative 	representative 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
recommendations  	recommendations  	 NNS	B-NP
identify  	identify  	 VBP	O
( 	( 	 -LRB-	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
sensitized  	sensitized  	 JJ	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
SOT  	SOT  	 NNS	I-NP
that  	that  	 WDT	O
would  	would  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
better  	better  	 JJR	O
survival  	survival  	 NN	O
and  	and  	 CC	O
decreased  	decreased  	 JJ	O
morbidity  	morbidity  	 NN	O
by  	by  	 IN	O
receiving  	receiving  	 VBG	B-NP
IG  	IG  	 NNP	I-NP
preoperatively 	preoperatively 	 NN	O
,  	,  	 ,	O
postoperatively 	postoperatively 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
organ  	organ  	 JJ	B-NP
rejection 	rejection 	 NN	I-NP
;  	;  	 :	O
( 	( 	 -LRB-	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
may  	may  	 MD	O
not  	not  	 RB	O
have  	have  	 VB	O
any  	any  	 DT	O
benefit  	benefit  	 NN	O
from  	from  	 IN	O
receiving  	receiving  	 VBG	B-NP
IG 	IG 	 NNP	I-NP
;  	;  	 :	O
and  	and  	 CC	O
( 	( 	 -LRB-	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
potential  	potential  	 JJ	B-NP
adversities  	adversities  	 NN	I-NP
to  	to  	 TO	O
IG 	IG 	 NNP	B-NP
.  	.  	 .	O
